4
Industry Institute Partnership Cell Sree Chitra Tirunal Institute for Medical Sciences & Technology an institute of national importance under Department of Science & Technology, Government of India Regulatory Toxicologic Pathology, Module IV Toxicologic Pathology of Skin & Musculoskeletal System and Toxicologic Pathology of Biomedical Devices August 9-11, 2018

Regulatory Toxicologic Pathology, Module IV - … SCTIMST/Organisation/BioMedical...Toxicologic Pathology of Skin & Musculoskeletal System and Toxicologic Pathology of Biomedical Devices

  • Upload
    buidiep

  • View
    219

  • Download
    0

Embed Size (px)

Citation preview

Industry Institute Partnership Cell

Sree Chitra Tirunal Institute forMedical Sciences & Technology

an institute of national importance underDepartment of Science & Technology, Government of India

Regulatory Toxicologic Pathology, Module IVToxicologic Pathology of Skin & Musculoskeletal System

and Toxicologic Pathology of Biomedical Devices

August 9-11, 2018

Toxicologic Pathology of Skin & Musculoskeletal System

and Toxicologic Pathology of Biomedical DevicesAugust 9-11, 2018

Sree Chitra Tirunal Institute for Medical Sciences and Technology organises Modular Courses in 'Regulatory Toxicologic Pathology'. The

course has the close supervision of Dr C Gopinath, an internationally acclaimed toxicologic pathologist practising the discipline in UK who. .

acts as the 'Course Adviser' for the programme, with a range of international faculty. The first three modules were organised in February 2017,

August 2017 and February 2018 respectively and the international faculty included Dr C Gopinath (UK), Dr M R Alison (UK), Dr K. . . . . . .

Weber (Switzerland), Dr P Mullins (UK), Dr J R Foster (UK), Dr V Mowat (UK) and Dr Nigel Roome (France). Participants. . . . . . . .

representing industry, academia, research community and graduate students attended the courses.

After the successful conduct of the first three modules, the organisers announce the Module-IV (Thursday, 9 Saturday, 11 Augustth th

August to

2018) on the following topics.

� Toxicologic Pathology of skin

� Toxicologic Pathology of musculoskeletal system

� Biocompatibility testing of biomaterials

� Safety evaluation of biomedical devices

The course is intended for Toxicologic Pathologists (as a refresher course) and recent graduates considering to take Toxicologic Pathology as

a career speciality. However, participants from academia, research-community and graduate students have also attended the previous

modules and found the course useful for advancing their areas of expertise on drug discovery and teaching/training.

Dr Chirukandath Gopinath is an.independent consultant in Toxicologicalpathology working from UK. He took hisveterinary degree at Kerala VeterinaryCollege, India. His postgraduatequalifications were from the University ofLiverpool, UK where he also worked aslecturer in veterinary pathology.

He was director of pathology and chiefscientific officer at Huntingdon Researchcentre, Huntingdon, UK for several years.During his career in toxicological pathologyhe had held positions of President, BSTP,IFSTP and European director of IATP,chairman of board of examiners inVeterinary Pathology, Royal College ofPathology, London. He has chaired andparticipated in several PWGs and SAGssolving pathology issues. Dr Gopinath has.published several papers in peer-reviewedjournals and authored a few books andchapters in topics of toxicological pathology.He also has conducted educational seminarson topics in toxicologic pathology in differentparts of the world.

Dr Vasanthi Mowat is the Director of.Pathology at Envigo laboratories atHuntingdon, UK, where she manages theHistology, Necropsy, Pathology andSpecial Pathology Services Units. She hasover 25 years' experience as a toxicologicalpathologist and has worked at CROs inBritain and France.

She joined Envigo in April 2006 and wasappointed as Director of Pathology inFebruary 2008. She is a member of theINHAND Cardiovascular working Groupof the Society of Toxicological Pathologistsand has made several presentations oncardiovascular pathology, in which she hasa specialist interest. She graduated as aveterinarian in Bangalore, India, where shealso gained a Master's degree in VeterinaryPathology. She was awarded the FRCPathin 2004. She has published and presentedmany papers on procedural andbackground findings in a variety of speciesand study types at international meetingsand conferences. In 2014 she co-authoredan atlas of toxicological pathology withDr C Gopinath.. .

Dr. Serge Rousselle has extensiveexperience (20+ years) in drug safetyassessment gained while employed with orconsulting for the pharmaceutical industry(Pfizer) and employed in contractresearch organizations (currently at AlizéePathology).

Dr. Rousselle current area of focus andexpertise is in evaluation and oversight ofmedical device studies. Alizée Pathologyroutinely prepares customized processes,immunohistochemistry protocols andspecial stains for device studies andevaluation of animal models of humandiseases, using frozen and fixed tissue,including paraffin and plastic embeddedtissue. Dr. Rousselle is an active memberof ACVP and STP and has co-authored35 journal articles and many abstractspresented at international conventions.

Dr. Chirukandath Gopinath Dr. Vasanthi Mowat Dr. Serge Rousselle

Dr T V Anilkumar, PhD. . .Scientist (Experimental Pathology)Biomedical Technology Wing, Satelmond Palace CampusSree Sree Chitra Tirunal Institute for medical Sciences and Technology,Poojappura, Thiruvananthapuram 695012Phone: +91 94470 17506 E-mail: [email protected]

Contact for any furtherIIPCinformation or registrations.

E-mail: [email protected]: 0471 2520 307/310

Course Director

International Faculty

Payments

Demand Draft in favour of “The Director, SCTIMST” payable

at Thiruvananthapuram OR by Online Transfer - Bank details

of the Institute: SCTIMST

Account Number: 57001148263IFSC Code: SBIN0070032Bank: State Bank of IndiaBranch: Poojappura BranchPAN Number: AAAJS0437MGST No: 32AAAJS0437M1Z4

Registration

Please note that attendance is restricted tothe

registered candidates. Registration will be “on a first

come first serve basis”. There .is no 'spot registration'

Last ate of registration is .d 30 July 2018th

Course fee

Rs ,000. 20 /- (18% GST included) per head

Rs /-. 10,000 (18% GST included) per head for one day

Sree Chitra Tirunal Institute for Medical Sciences & Technology (SCTIMST) has played a pioneering role in the developmentof medical devices industry in India by developing and successfully commercializing a wide range of biomedical devices andimplants such as the Heart Valve, Blood Bag, Oxygenator, Vascular Graft, Hydrocephalus Shunt, Haemoconcentrator, DentalComposites, Bioactive Composites for Orthopedics, Emily IUS etc.

The Biomedical Technology Wing of the SCTIMST has been engaged in the research and development of medical devices andbiomaterials and has built up extensive expertise and facilities. Its laboratories are now accredited by COFRAC, France underISO/IEC 17025 for testing of medical devices and materials.

The process of medical device development is complex and need inputs from varied disciplines of science and technology. Theprocess of medical device development and associated aligned areas of biomedical technology therefore requires extensivelearning.

Biomedical Technology Wing of SCTIMST has traveled through this arena for more than thirty years now. The medical deviceindustry being at a budding stage in India and various start ups emerging, the Institute recognizes that the expertise andexperience that has been gained through the years are to be shared with the medical device industry, the researchers andstudents.

The Institute has its Industry Institute Partnership Cell (IIPC) with focus on services like training, problem solving andconsultancy in existence for more than a decade now. To support the medical device industry and the start ups in enhancedlearning of Biomedical Technology, the IIPC now launches a series of training programs which shall be pre-scheduled for theentire year on various selected topics.

The participants are free to register to any of the programs of IIPC before the last date of registration. If any custom madetraining programs are to be arranged, the same shall be entertained by IIPC subject to the mutual convenience. You may conveythe same to us through our email.

“Learning is the only thing the mind

never exhausts, never fears, and never regrets”........ Leonardo da Vinci

Dr. T.V. Anilkumar is a Scientist-Gof Sree Chitra Tirunal Institute forMedical Sciences and Technology,Thiruvananthapuram, an institute ofnational importance under theGovernment of India which has amajor objective of developingbiomedical devices. He heads theDivision of Experimental Pathology atthe Biomedical Technology Wing,

which includes a Histopathology Laboratory accredited to ISO17025 system for testing of biomaterials. Dr Anilkumar hascompeted MSc (Experimental Pathology and Toxicology) andPhD of the University of London at the Imperial CollegeSchool of Medicine at Hammersmith. He has 17 years ofexperience in development and evaluation of biomedicaldevices. He has co-authored over 50 peer reviewed journalarticles. He is a Fellow of the International Academy ofToxicologic Pathology, the President of the Indian College ofVeterinary Pathologists and the Immediate Past President ofthe Asian Society of Veterinary Pathology.

Dr. A. Sabareeswaran is a Scientist andthe Department Co-ordinator, Departmentof Applied Biology, Biomedical TechnologyWing. Sree Chitra Tirunal Institute forMedical Sciences and Technology.Thiruvananthapuram. He is basically aVeterinary graduate and holds a Masterdegree in Veterinary Pathology andDoctorate degree in Nanomedicine. He has12 years of experience in evaluation ofbiomaterials and medical devices as per

international standard in an accredited Histopathology laboratory.As study pathologist in preclinical studies, he has evaluated medicaldevices like mechanical heart valve, biological heart valve, leftventricular assist devices, haemoconcentrator, blood oxygenator,coronary stents (bare, drug eluting, degradable), large diametervascular grafts, ureteric stents, bone implants, dental implants,neuroprosthetics, decellularised scaffolds, wound care products,tissue engineered vascular grafts, keratoprosthesis and artificialcornea etc. He has published more than 20 research articles in peerreviewed journals and a book namely “Color atlas of tissueresponse to biomaterials and medical devices”.

Faculty

For further enquiries

The Co-ordinator

Industry Institute Partnership Cell

Sree Chitra Tirunal Institute for Medical Sciences & Technology

Thiruvananthapuram 695012, India

Telephone: +91 471 2520 207/307/310

E-mail enquiries: [email protected]

www.sctimst.ac.in

facebook.com/sctimst.trivandrum

twitter.com/sctimst_tvm

youtube.com/channel/UC_4EoiTEIYMsuSDDEWQo1rQ

Disclaimer: The information in this publication is current as at the

date of printing and is subject to change. You can find updated

information on our website at . With the aim ofsctimst.ac.in

continual improvement is committed to regular review ofSCTIMST

the training courses on offer, and the specific programs and courses

available will change from time to time. Please refer to sctimst.ac.in

for the most up to date information or contact us on +91 471 2520

207/307/310. SCTIMST assumes no responsibility for the accuracy

of information provided by third parties.

The Industry Institute Partnership Cell (IIPC) was initiated with

an approval and funding from AICTE, New Delhi and subsequently

encouraged and stabilized by SCTIMST with a mandate to develop

awareness and relevance of quality consciousness in the

development of biomedical technology in the minds of industrial

personnel in India. The IIPC intends to do this through a series of

structured symposiums and appropriate workshops. Participants are

offered an opportunity to learn from and share the expertise built by

the institute. They can interact with the faculty, have laboratory

visits and exposure to the facilities and expertise available and

explore future collaborative programmes.

Published May 2018